TP63 and EEC syndrome: As EEC syndrome results from heterozygous dominant-negative mutations in the p63 gene, AS gene silencing through RNAi is a viable option to specifically inhibit the expression of the disease-associated allele without suppressing the expression of the corresponding wild-type (WT) copy.